Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion description "[We engineered the human NSCLC cell line PC-9 (MET-positive cells harboring an exon 19 deletion of EGFR) to overexpress hHGF and evaluated the effects of an onartuzumab and erlotinib combination in vitro and in vivo in xenograft models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion evidence source_evidence_literature NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion SIO_000772 25522765 NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion wasDerivedFrom befree-2016 NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_assertion wasGeneratedBy ECO_0000203 NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.
- befree-2016 importedOn "2016-02-19" NP1249317.RA6CeU5_z50j42ucOwRaJuJwIhP9L53xw3RRTU9Yuu2Fc130_provenance.